135 related articles for article (PubMed ID: 34964983)
21. Textbook Outcome and Survival in Patients With Gastric Cancer: An Analysis of the Population Registry of Esophageal and Stomach Tumours in Ontario (PRESTO).
Levy J; Gupta V; Amirazodi E; Allen-Ayodabo C; Jivraj N; Jeong Y; Davis LE; Mahar AL; De Mestral C; Saarela O; Coburn NG;
Ann Surg; 2022 Jan; 275(1):140-148. PubMed ID: 32149825
[TBL] [Abstract][Full Text] [Related]
22. Oncologic specimen from laparoscopic assisted gastrectomy for gastric adenocarcinoma is comparable to D1-open surgery: the experience of a Canadian centre.
Hallet J; Labidi S; Bouchard-Fortier A; Clairoux A; Gagné JP
Can J Surg; 2013 Aug; 56(4):249-55. PubMed ID: 23883495
[TBL] [Abstract][Full Text] [Related]
23. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
[TBL] [Abstract][Full Text] [Related]
24. Minimally invasive gastrectomy for gastric adenocarcinoma in the United States: Utilization and short-term oncologic outcomes.
Ecker BL; Datta J; McMillan MT; Poe SL; Drebin JA; Fraker DL; Dempsey DT; Karakousis GC; Roses RE
J Surg Oncol; 2015 Nov; 112(6):616-21. PubMed ID: 26394810
[TBL] [Abstract][Full Text] [Related]
25. Urgent Surgery for Gastric Adenocarcinoma: A Study of the National Cancer Database.
Fisher BW; Fluck M; Young K; Shabahang M; Blansfield J; Arora TK
J Surg Res; 2020 Jan; 245():619-628. PubMed ID: 31522035
[TBL] [Abstract][Full Text] [Related]
26. Survival benefit of greater number of lymph nodes dissection for advanced node-negative gastric cancer patients following radical gastrectomy.
He H; Shen Z; Wang X; Qin J; Sun Y; Qin X
Jpn J Clin Oncol; 2016 Jan; 46(1):63-70. PubMed ID: 26497044
[TBL] [Abstract][Full Text] [Related]
27. Surgical care quality and oncologic outcome after D2 gastrectomy for gastric cancer.
Mrena J; Mattila A; Böhm J; Jantunen I; Kellokumpu I
World J Gastroenterol; 2015 Dec; 21(47):13294-301. PubMed ID: 26715812
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
[TBL] [Abstract][Full Text] [Related]
29. Young Age and Risk of Lymph Node Metastasis in Differentiated Type Early Gastric Cancer.
Pyo JH; Lee H; Min YW; Min BH; Lee JH; Kim KM; Yoo H; Kim K; Choi YH; Kim JJ; Kim S
Ann Surg Oncol; 2018 Sep; 25(9):2713-2719. PubMed ID: 30006689
[TBL] [Abstract][Full Text] [Related]
30. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
[TBL] [Abstract][Full Text] [Related]
31. Textbook outcome and survival of robotic versus laparoscopic total gastrectomy for gastric cancer: a propensity score matched cohort study.
Roh CK; Lee S; Son SY; Hur H; Han SU
Sci Rep; 2021 Jul; 11(1):15394. PubMed ID: 34321568
[TBL] [Abstract][Full Text] [Related]
32. Laparoscopic-assisted Versus Open D2 Gastrectomy for Advanced Gastric Cancer in Highly Selective Patients: Short-term Surgical and Chemotherapy Outcomes of a Prospective Cohort Study.
Huang X; Du H; Aihemaiti M; Liu T; Chen N; Yu W; Hu S; Liu S
Am J Clin Oncol; 2019 May; 42(5):459-465. PubMed ID: 30883390
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic factors of lymph node-negative metastasis gastric cancer].
Sun D; Xu H; Huang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):190-194. PubMed ID: 28226354
[TBL] [Abstract][Full Text] [Related]
34. Assessment of textbook oncologic outcomes following pancreaticoduodenectomy for pancreatic adenocarcinoma.
Sweigert PJ; Eguia E; Baker MS; Paredes AZ; Tsilimigras DI; Dillhoff M; Ejaz A; Cloyd J; Tsung A; Pawlik TM
J Surg Oncol; 2020 May; 121(6):936-944. PubMed ID: 32124437
[TBL] [Abstract][Full Text] [Related]
35. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
36. Prognosis for gastric carcinomas with an insufficient number of examined negative lymph nodes.
Martinez-Ramos D; Calero A; Escrig-Sos J; Mingol F; Daroca-Jose JM; Sauri M; Arroyo A; Salvador-Sanchis JL; de Juan M; Calpena R; Lacueva FJ
Eur J Surg Oncol; 2014 Mar; 40(3):358-65. PubMed ID: 24075824
[TBL] [Abstract][Full Text] [Related]
37. Minimally invasive gastrectomy for gastric cancer: A national perspective on oncologic outcomes and overall survival.
Leung K; Sun Z; Nussbaum DP; Adam MA; Worni M; Blazer DG
Surg Oncol; 2017 Sep; 26(3):324-330. PubMed ID: 28807254
[TBL] [Abstract][Full Text] [Related]
38. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
39. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
Volpe CM; Driscoll DL; Douglass HO
Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
[TBL] [Abstract][Full Text] [Related]
40. Factors Associated With Recurrence and Survival in Lymph Node-negative Gastric Adenocarcinoma: A 7-Institution Study of the US Gastric Cancer Collaborative.
Jin LX; Moses LE; Squires MH; Poultsides GA; Votanopoulos K; Weber SM; Bloomston M; Pawlik TM; Hawkins WG; Linehan DC; Strasberg SM; Schmidt C; Worhunsky DJ; Acher AW; Cardona K; Cho CS; Kooby DA; Levine E; Winslow ER; Saunders ND; Spolverato G; Maithel SK; Fields RC
Ann Surg; 2015 Dec; 262(6):999-1005. PubMed ID: 25607760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
